Anti-VEGF Medicine and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Anti-VEGF Medicine Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Anti-VEGF Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-VEGF Medicine Overall Market Size
2.1 Global Anti-VEGF Medicine Market Size: 2024 VS 2032
2.2 Global Anti-VEGF Medicine Market Size, Prospects & Forecasts: 2020-2032
2.3 Global Anti-VEGF Medicine Sales: 2020-2032
3 Company Landscape
3.1 Top Anti-VEGF Medicine Players in Global Market
3.2 Top Global Anti-VEGF Medicine Companies Ranked by Revenue
3.3 Global Anti-VEGF Medicine Revenue by Companies
3.4 Global Anti-VEGF Medicine Sales by Companies
3.5 Global Anti-VEGF Medicine Price by Manufacturer (2020-2025)
3.6 Top 3 and Top 5 Anti-VEGF Medicine Companies in Global Market, by Revenue in 2024
3.7 Global Manufacturers Anti-VEGF Medicine Product Type
3.8 Tier 1, Tier 2, and Tier 3 Anti-VEGF Medicine Players in Global Market
3.8.1 List of Global Tier 1 Anti-VEGF Medicine Companies
3.8.2 List of Global Tier 2 and Tier 3 Anti-VEGF Medicine Companies
4 Sights by Product
4.1 Overview
4.1.1 Segment by Type - Global Anti-VEGF Medicine Market Size Markets, 2024 & 2032
4.1.2 Single Target (Ranibizumab, etc.)
4.1.3 Multiple Targets (Aflibercept, Conbercept, etc.)
4.2 Segment by Type - Global Anti-VEGF Medicine Revenue & Forecasts
4.2.1 Segment by Type - Global Anti-VEGF Medicine Revenue, 2020-2025
4.2.2 Segment by Type - Global Anti-VEGF Medicine Revenue, 2026-2032
4.2.3 Segment by Type - Global Anti-VEGF Medicine Revenue Market Share, 2020-2032
4.3 Segment by Type - Global Anti-VEGF Medicine Sales & Forecasts
4.3.1 Segment by Type - Global Anti-VEGF Medicine Sales, 2020-2025
4.3.2 Segment by Type - Global Anti-VEGF Medicine Sales, 2026-2032
4.3.3 Segment by Type - Global Anti-VEGF Medicine Sales Market Share, 2020-2032
4.4 Segment by Type - Global Anti-VEGF Medicine Price (Manufacturers Selling Prices), 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segment by Application - Global Anti-VEGF Medicine Market Size, 2024 & 2032
5.1.2 Hospital
5.1.3 Eye Clinic
5.1.4 Other
5.2 Segment by Application - Global Anti-VEGF Medicine Revenue & Forecasts
5.2.1 Segment by Application - Global Anti-VEGF Medicine Revenue, 2020-2025
5.2.2 Segment by Application - Global Anti-VEGF Medicine Revenue, 2026-2032
5.2.3 Segment by Application - Global Anti-VEGF Medicine Revenue Market Share, 2020-2032
5.3 Segment by Application - Global Anti-VEGF Medicine Sales & Forecasts
5.3.1 Segment by Application - Global Anti-VEGF Medicine Sales, 2020-2025
5.3.2 Segment by Application - Global Anti-VEGF Medicine Sales, 2026-2032
5.3.3 Segment by Application - Global Anti-VEGF Medicine Sales Market Share, 2020-2032
5.4 Segment by Application - Global Anti-VEGF Medicine Price (Manufacturers Selling Prices), 2020-2032
6 Sights by Region
6.1 By Region - Global Anti-VEGF Medicine Market Size, 2024 & 2032
6.2 By Region - Global Anti-VEGF Medicine Revenue & Forecasts
6.2.1 By Region - Global Anti-VEGF Medicine Revenue, 2020-2025
6.2.2 By Region - Global Anti-VEGF Medicine Revenue, 2026-2032
6.2.3 By Region - Global Anti-VEGF Medicine Revenue Market Share, 2020-2032
6.3 By Region - Global Anti-VEGF Medicine Sales & Forecasts
6.3.1 By Region - Global Anti-VEGF Medicine Sales, 2020-2025
6.3.2 By Region - Global Anti-VEGF Medicine Sales, 2026-2032
6.3.3 By Region - Global Anti-VEGF Medicine Sales Market Share, 2020-2032
6.4 North America
6.4.1 By Country - North America Anti-VEGF Medicine Revenue, 2020-2032
6.4.2 By Country - North America Anti-VEGF Medicine Sales, 2020-2032
6.4.3 United States Anti-VEGF Medicine Market Size, 2020-2032
6.4.4 Canada Anti-VEGF Medicine Market Size, 2020-2032
6.4.5 Mexico Anti-VEGF Medicine Market Size, 2020-2032
6.5 Europe
6.5.1 By Country - Europe Anti-VEGF Medicine Revenue, 2020-2032
6.5.2 By Country - Europe Anti-VEGF Medicine Sales, 2020-2032
6.5.3 Germany Anti-VEGF Medicine Market Size, 2020-2032
6.5.4 France Anti-VEGF Medicine Market Size, 2020-2032
6.5.5 U.K. Anti-VEGF Medicine Market Size, 2020-2032
6.5.6 Italy Anti-VEGF Medicine Market Size, 2020-2032
6.5.7 Russia Anti-VEGF Medicine Market Size, 2020-2032
6.5.8 Nordic Countries Anti-VEGF Medicine Market Size, 2020-2032
6.5.9 Benelux Anti-VEGF Medicine Market Size, 2020-2032
6.6 Asia
6.6.1 By Region - Asia Anti-VEGF Medicine Revenue, 2020-2032
6.6.2 By Region - Asia Anti-VEGF Medicine Sales, 2020-2032
6.6.3 China Anti-VEGF Medicine Market Size, 2020-2032
6.6.4 Japan Anti-VEGF Medicine Market Size, 2020-2032
6.6.5 South Korea Anti-VEGF Medicine Market Size, 2020-2032
6.6.6 Southeast Asia Anti-VEGF Medicine Market Size, 2020-2032
6.6.7 India Anti-VEGF Medicine Market Size, 2020-2032
6.7 South America
6.7.1 By Country - South America Anti-VEGF Medicine Revenue, 2020-2032
6.7.2 By Country - South America Anti-VEGF Medicine Sales, 2020-2032
6.7.3 Brazil Anti-VEGF Medicine Market Size, 2020-2032
6.7.4 Argentina Anti-VEGF Medicine Market Size, 2020-2032
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Anti-VEGF Medicine Revenue, 2020-2032
6.8.2 By Country - Middle East & Africa Anti-VEGF Medicine Sales, 2020-2032
6.8.3 Turkey Anti-VEGF Medicine Market Size, 2020-2032
6.8.4 Israel Anti-VEGF Medicine Market Size, 2020-2032
6.8.5 Saudi Arabia Anti-VEGF Medicine Market Size, 2020-2032
6.8.6 UAE Anti-VEGF Medicine Market Size, 2020-2032
7 Manufacturers & Brands Profiles
7.1 Faricimab
7.1.1 Faricimab Company Summary
7.1.2 Faricimab Business Overview
7.1.3 Faricimab Anti-VEGF Medicine Major Product Offerings
7.1.4 Faricimab Anti-VEGF Medicine Sales and Revenue in Global (2020-2025)
7.1.5 Faricimab Key News & Latest Developments
7.2 Bayer (Regeneron)
7.2.1 Bayer (Regeneron) Company Summary
7.2.2 Bayer (Regeneron) Business Overview
7.2.3 Bayer (Regeneron) Anti-VEGF Medicine Major Product Offerings
7.2.4 Bayer (Regeneron) Anti-VEGF Medicine Sales and Revenue in Global (2020-2025)
7.2.5 Bayer (Regeneron) Key News & Latest Developments
7.3 Brolucizumab
7.3.1 Brolucizumab Company Summary
7.3.2 Brolucizumab Business Overview
7.3.3 Brolucizumab Anti-VEGF Medicine Major Product Offerings
7.3.4 Brolucizumab Anti-VEGF Medicine Sales and Revenue in Global (2020-2025)
7.3.5 Brolucizumab Key News & Latest Developments
7.4 Kanghong Pharmaceutical
7.4.1 Kanghong Pharmaceutical Company Summary
7.4.2 Kanghong Pharmaceutical Business Overview
7.4.3 Kanghong Pharmaceutical Anti-VEGF Medicine Major Product Offerings
7.4.4 Kanghong Pharmaceutical Anti-VEGF Medicine Sales and Revenue in Global (2020-2025)
7.4.5 Kanghong Pharmaceutical Key News & Latest Developments
7.5 Santen
7.5.1 Santen Company Summary
7.5.2 Santen Business Overview
7.5.3 Santen Anti-VEGF Medicine Major Product Offerings
7.5.4 Santen Anti-VEGF Medicine Sales and Revenue in Global (2020-2025)
7.5.5 Santen Key News & Latest Developments
8 Global Anti-VEGF Medicine Production Capacity, Analysis
8.1 Global Anti-VEGF Medicine Production Capacity, 2020-2032
8.2 Anti-VEGF Medicine Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-VEGF Medicine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anti-VEGF Medicine Supply Chain Analysis
10.1 Anti-VEGF Medicine Industry Value Chain
10.2 Anti-VEGF Medicine Upstream Market
10.3 Anti-VEGF Medicine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anti-VEGF Medicine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Anti-VEGF Medicine in Global Market
Table 2. Top Anti-VEGF Medicine Players in Global Market, Ranking by Revenue (2024)
Table 3. Global Anti-VEGF Medicine Revenue by Companies, (US$, Mn), 2020-2025
Table 4. Global Anti-VEGF Medicine Revenue Share by Companies, 2020-2025
Table 5. Global Anti-VEGF Medicine Sales by Companies, (K Units), 2020-2025
Table 6. Global Anti-VEGF Medicine Sales Share by Companies, 2020-2025
Table 7. Key Manufacturers Anti-VEGF Medicine Price (2020-2025) & (US$/Unit)
Table 8. Global Manufacturers Anti-VEGF Medicine Product Type
Table 9. List of Global Tier 1 Anti-VEGF Medicine Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-VEGF Medicine Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segment by Type � Global Anti-VEGF Medicine Revenue, (US$, Mn), 2024 & 2032
Table 12. Segment by Type - Global Anti-VEGF Medicine Revenue (US$, Mn), 2020-2025
Table 13. Segment by Type - Global Anti-VEGF Medicine Revenue (US$, Mn), 2026-2032
Table 14. Segment by Type - Global Anti-VEGF Medicine Sales (K Units), 2020-2025
Table 15. Segment by Type - Global Anti-VEGF Medicine Sales (K Units), 2026-2032
Table 16. Segment by Application � Global Anti-VEGF Medicine Revenue, (US$, Mn), 2024 & 2032
Table 17. Segment by Application - Global Anti-VEGF Medicine Revenue, (US$, Mn), 2020-2025
Table 18. Segment by Application - Global Anti-VEGF Medicine Revenue, (US$, Mn), 2026-2032
Table 19. Segment by Application - Global Anti-VEGF Medicine Sales, (K Units), 2020-2025
Table 20. Segment by Application - Global Anti-VEGF Medicine Sales, (K Units), 2026-2032
Table 21. By Region � Global Anti-VEGF Medicine Revenue, (US$, Mn), 2025-2032
Table 22. By Region - Global Anti-VEGF Medicine Revenue, (US$, Mn), 2020-2025
Table 23. By Region - Global Anti-VEGF Medicine Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Global Anti-VEGF Medicine Sales, (K Units), 2020-2025
Table 25. By Region - Global Anti-VEGF Medicine Sales, (K Units), 2026-2032
Table 26. By Country - North America Anti-VEGF Medicine Revenue, (US$, Mn), 2020-2025
Table 27. By Country - North America Anti-VEGF Medicine Revenue, (US$, Mn), 2026-2032
Table 28. By Country - North America Anti-VEGF Medicine Sales, (K Units), 2020-2025
Table 29. By Country - North America Anti-VEGF Medicine Sales, (K Units), 2026-2032
Table 30. By Country - Europe Anti-VEGF Medicine Revenue, (US$, Mn), 2020-2025
Table 31. By Country - Europe Anti-VEGF Medicine Revenue, (US$, Mn), 2026-2032
Table 32. By Country - Europe Anti-VEGF Medicine Sales, (K Units), 2020-2025
Table 33. By Country - Europe Anti-VEGF Medicine Sales, (K Units), 2026-2032
Table 34. By Region - Asia Anti-VEGF Medicine Revenue, (US$, Mn), 2020-2025
Table 35. By Region - Asia Anti-VEGF Medicine Revenue, (US$, Mn), 2026-2032
Table 36. By Region - Asia Anti-VEGF Medicine Sales, (K Units), 2020-2025
Table 37. By Region - Asia Anti-VEGF Medicine Sales, (K Units), 2026-2032
Table 38. By Country - South America Anti-VEGF Medicine Revenue, (US$, Mn), 2020-2025
Table 39. By Country - South America Anti-VEGF Medicine Revenue, (US$, Mn), 2026-2032
Table 40. By Country - South America Anti-VEGF Medicine Sales, (K Units), 2020-2025
Table 41. By Country - South America Anti-VEGF Medicine Sales, (K Units), 2026-2032
Table 42. By Country - Middle East & Africa Anti-VEGF Medicine Revenue, (US$, Mn), 2020-2025
Table 43. By Country - Middle East & Africa Anti-VEGF Medicine Revenue, (US$, Mn), 2026-2032
Table 44. By Country - Middle East & Africa Anti-VEGF Medicine Sales, (K Units), 2020-2025
Table 45. By Country - Middle East & Africa Anti-VEGF Medicine Sales, (K Units), 2026-2032
Table 46. Faricimab Company Summary
Table 47. Faricimab Anti-VEGF Medicine Product Offerings
Table 48. Faricimab Anti-VEGF Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 49. Faricimab Key News & Latest Developments
Table 50. Bayer (Regeneron) Company Summary
Table 51. Bayer (Regeneron) Anti-VEGF Medicine Product Offerings
Table 52. Bayer (Regeneron) Anti-VEGF Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 53. Bayer (Regeneron) Key News & Latest Developments
Table 54. Brolucizumab Company Summary
Table 55. Brolucizumab Anti-VEGF Medicine Product Offerings
Table 56. Brolucizumab Anti-VEGF Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 57. Brolucizumab Key News & Latest Developments
Table 58. Kanghong Pharmaceutical Company Summary
Table 59. Kanghong Pharmaceutical Anti-VEGF Medicine Product Offerings
Table 60. Kanghong Pharmaceutical Anti-VEGF Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 61. Kanghong Pharmaceutical Key News & Latest Developments
Table 62. Santen Company Summary
Table 63. Santen Anti-VEGF Medicine Product Offerings
Table 64. Santen Anti-VEGF Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 65. Santen Key News & Latest Developments
Table 66. Anti-VEGF Medicine Capacity of Key Manufacturers in Global Market, 2023-2025 (K Units)
Table 67. Global Anti-VEGF Medicine Capacity Market Share of Key Manufacturers, 2023-2025
Table 68. Global Anti-VEGF Medicine Production by Region, 2020-2025 (K Units)
Table 69. Global Anti-VEGF Medicine Production by Region, 2026-2032 (K Units)
Table 70. Anti-VEGF Medicine Market Opportunities & Trends in Global Market
Table 71. Anti-VEGF Medicine Market Drivers in Global Market
Table 72. Anti-VEGF Medicine Market Restraints in Global Market
Table 73. Anti-VEGF Medicine Raw Materials
Table 74. Anti-VEGF Medicine Raw Materials Suppliers in Global Market
Table 75. Typical Anti-VEGF Medicine Downstream
Table 76. Anti-VEGF Medicine Downstream Clients in Global Market
Table 77. Anti-VEGF Medicine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Anti-VEGF Medicine Product Picture
Figure 2. Anti-VEGF Medicine Segment by Type in 2024
Figure 3. Anti-VEGF Medicine Segment by Application in 2024
Figure 4. Global Anti-VEGF Medicine Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Anti-VEGF Medicine Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Anti-VEGF Medicine Revenue: 2020-2032 (US$, Mn)
Figure 8. Anti-VEGF Medicine Sales in Global Market: 2020-2032 (K Units)
Figure 9. The Top 3 and 5 Players Market Share by Anti-VEGF Medicine Revenue in 2024
Figure 10. Segment by Type � Global Anti-VEGF Medicine Revenue, (US$, Mn), 2024 & 2032
Figure 11. Segment by Type - Global Anti-VEGF Medicine Revenue Market Share, 2020-2032
Figure 12. Segment by Type - Global Anti-VEGF Medicine Sales Market Share, 2020-2032
Figure 13. Segment by Type - Global Anti-VEGF Medicine Price (US$/Unit), 2020-2032
Figure 14. Segment by Application � Global Anti-VEGF Medicine Revenue, (US$, Mn), 2024 & 2032
Figure 15. Segment by Application - Global Anti-VEGF Medicine Revenue Market Share, 2020-2032
Figure 16. Segment by Application - Global Anti-VEGF Medicine Sales Market Share, 2020-2032
Figure 17. Segment by Application -Global Anti-VEGF Medicine Price (US$/Unit), 2020-2032
Figure 18. By Region � Global Anti-VEGF Medicine Revenue, (US$, Mn), 2025 & 2032
Figure 19. By Region - Global Anti-VEGF Medicine Revenue Market Share, 2020 VS 2024 VS 2032
Figure 20. By Region - Global Anti-VEGF Medicine Revenue Market Share, 2020-2032
Figure 21. By Region - Global Anti-VEGF Medicine Sales Market Share, 2020-2032
Figure 22. By Country - North America Anti-VEGF Medicine Revenue Market Share, 2020-2032
Figure 23. By Country - North America Anti-VEGF Medicine Sales Market Share, 2020-2032
Figure 24. United States Anti-VEGF Medicine Revenue, (US$, Mn), 2020-2032
Figure 25. Canada Anti-VEGF Medicine Revenue, (US$, Mn), 2020-2032
Figure 26. Mexico Anti-VEGF Medicine Revenue, (US$, Mn), 2020-2032
Figure 27. By Country - Europe Anti-VEGF Medicine Revenue Market Share, 2020-2032
Figure 28. By Country - Europe Anti-VEGF Medicine Sales Market Share, 2020-2032
Figure 29. Germany Anti-VEGF Medicine Revenue, (US$, Mn), 2020-2032
Figure 30. France Anti-VEGF Medicine Revenue, (US$, Mn), 2020-2032
Figure 31. U.K. Anti-VEGF Medicine Revenue, (US$, Mn), 2020-2032
Figure 32. Italy Anti-VEGF Medicine Revenue, (US$, Mn), 2020-2032
Figure 33. Russia Anti-VEGF Medicine Revenue, (US$, Mn), 2020-2032
Figure 34. Nordic Countries Anti-VEGF Medicine Revenue, (US$, Mn), 2020-2032
Figure 35. Benelux Anti-VEGF Medicine Revenue, (US$, Mn), 2020-2032
Figure 36. By Region - Asia Anti-VEGF Medicine Revenue Market Share, 2020-2032
Figure 37. By Region - Asia Anti-VEGF Medicine Sales Market Share, 2020-2032
Figure 38. China Anti-VEGF Medicine Revenue, (US$, Mn), 2020-2032
Figure 39. Japan Anti-VEGF Medicine Revenue, (US$, Mn), 2020-2032
Figure 40. South Korea Anti-VEGF Medicine Revenue, (US$, Mn), 2020-2032
Figure 41. Southeast Asia Anti-VEGF Medicine Revenue, (US$, Mn), 2020-2032
Figure 42. India Anti-VEGF Medicine Revenue, (US$, Mn), 2020-2032
Figure 43. By Country - South America Anti-VEGF Medicine Revenue Market Share, 2020-2032
Figure 44. By Country - South America Anti-VEGF Medicine Sales, Market Share, 2020-2032
Figure 45. Brazil Anti-VEGF Medicine Revenue, (US$, Mn), 2020-2032
Figure 46. Argentina Anti-VEGF Medicine Revenue, (US$, Mn), 2020-2032
Figure 47. By Country - Middle East & Africa Anti-VEGF Medicine Revenue, Market Share, 2020-2032
Figure 48. By Country - Middle East & Africa Anti-VEGF Medicine Sales, Market Share, 2020-2032
Figure 49. Turkey Anti-VEGF Medicine Revenue, (US$, Mn), 2020-2032
Figure 50. Israel Anti-VEGF Medicine Revenue, (US$, Mn), 2020-2032
Figure 51. Saudi Arabia Anti-VEGF Medicine Revenue, (US$, Mn), 2020-2032
Figure 52. UAE Anti-VEGF Medicine Revenue, (US$, Mn), 2020-2032
Figure 53. Global Anti-VEGF Medicine Production Capacity (K Units), 2020-2032
Figure 54. The Percentage of Production Anti-VEGF Medicine by Region, 2024 VS 2032
Figure 55. Anti-VEGF Medicine Industry Value Chain
Figure 56. Marketing Channels
Industry Market Size
